Filing Details
- Accession Number:
- 0001522767-23-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-01 19:59:39
- Reporting Period:
- 2023-04-27
- Accepted Time:
- 2023-05-01 19:59:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1522767 | Marimed Inc. | MRMD | Medicinal Chemicals & Botanical Products (2833) | 274672745 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789645 | R Jon Levine | C/O Marimed Inc. 10 Oceana Way Norwood, MA 02062 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-27 | 138,889 | $0.00 | 20,150,976 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-28 | 49,393 | $0.38 | 20,101,583 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 Per Share | Restricted Stock Units (RSU) | Disposition | 2023-04-27 | 138,889 | $0.00 | 138,889 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 694,444 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,684,640 | Indirect | By the Jon Levine Family Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 Per Share | Restricted Stock Units (RSU) | $0.00 | 140,000 | 140,000 | Direct | ||
| Common Stock, Par Value $.001 Per Share | Option to buy common stock | $0.90 | 2026-10-01 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock, Par Value $.001 Per Share | Option to buy common stock | $0.88 | 2026-07-09 | 5,000,000 | 5,000,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 140,000 | 140,000 | Direct | |
| 2026-10-01 | 5,000,000 | 5,000,000 | Direct |
| 2026-07-09 | 5,000,000 | 5,000,000 | Direct |
Footnotes
- RSUs convert to common stock on a one-for-one basis.
- Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the RSUs.
- The shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- The RSUs vest over a three year period in equal one-sixth installments every sis months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.
- The RSUs vest over a three year period of which 46,667 RSUs will vest on March 7, 2024 and thereafter, 23,333 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
- Immediately
Billionaire Hedge Funds
